EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)Open Access · CC BY 4.0

High Loss of Adipose Tissue During Neoadjuvant Chemotherapy Predicts Poor Prognosis in Patients With Gastric Cancer

Chiyu He, Kankai Zhu, Qingqu Guo, Li Chen, Dan Wu, Lele Lin, Xiaoyong Zhang, Qianyun Shen, Weihuai Liu, Qi Zhang, Xinbao Wang, Ping Hu und 11 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.70107 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Chiyu He und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Adipose Tissue, Neoadjuvant Therapy, Stomach Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research & Development Plan of Zhejiang Province, National Natural Science Foundation of China, Science and Technological Innovation Project for College Students in Zhejiang Province (Xinmiao Talent Plan).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastric cancer (GC) patients often have nutritional risks or malnutrition, and neoadjuvant chemotherapy (NAC) tends to exacerbate malnutrition. Body composition parameters are associated with the prognosis of GC patients. Little is known about body composition changes during NAC and its role in clinical outcomes.

Methods

This was a secondary analysis of a Phase 3, open‐label, multicentre, randomized clinical trial (RCT) (NCT01364376), assessing the usefulness, safety and efficacy of S‐1 plus oxaliplatin (SOX) vs. fluorouracil, leucovorin and oxaliplatin (FOLFOX) as a perioperative chemotherapy regimen for patients with locally advanced GC. Pre‐NAC and post‐NAC computer tomography (CT) were collected to evaluate the prognostic role of skeletal muscle, adipose tissue and their dynamic change. Overall survival (OS) and progression‐free survival (PFS) rates were calculated using the Kaplan–Meier method.

Results

A total of 583 patients from 12 Chinese hospitals were enrolled. After exclusion, 423 patients who proceeded to surgery were used for further analysis. The median age was 60 (IQR: 54, 66) years, and 133 patients (31.4%) were female. Prior to NAC, 132 (31.2%) patients were diagnosed with sarcopenia. There was no significant difference in overall survival between sarcopenia and non‐sarcopenia patients ( p = 0.363). During NAC, most patients suffered skeletal muscle (SM) loss ( n = 268, 63.4%), subcutaneous adipose tissue (SAT) loss ( n = 236, 55.8%) and visceral adipose tissue (VAT) loss ( n = 254, 60.0%). Patients with SAT loss > 12.5% had significantly worse PFS ( p = 0.005) and OS ( p = 0.003) than those without. Patients with VAT loss > 15% had significantly worse PFS ( p = 0.003) and OS ( p = 0.004) than the stable or gain group. Patients with SMI loss > 4.7% had significantly worse PFS ( p = 0.043) and showed a tendency of reduced OS ( p = 0.181) than those without. In patients without sarcopenia, the incidence of grade 3/4 neutropenia in the FOLFOX group was higher than that of the SOX group ( p = 0.019). In patients with myosteatosis, the incidence of Grade 3/4 thrombocytopenia in the SOX group was higher than that of the FOLFOX group ( p < 0.001).

Conclusion

In this RCT study, patients with GC experience significant losses of muscle and adipose tissue during NAC. A high level of adipose tissue or muscle loss during NAC is prognostic of reduced survival in patients with locally advanced GC. Assessing and monitoring body composition can predict prognosis and effectively guide individual nutrition intervention and the prevention of complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adipose TissueNeoadjuvant TherapyStomach NeoplasmsAgedFemaleHumansMaleMiddle AgedAntineoplastic Combined Chemotherapy ProtocolsBody CompositionPrognosis

Stichwörter der Autor:innen

adipose tissuecomputer tomographygastric cancermuscleneoadjuvant chemotherapy

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
  • Department of General Surgery, Beilun District People's Hospital, Ningbo, China.
  • Department of Gastrointestinal Surgery, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, China.
  • Department of Hepatopancreatobiliary Surgery, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China.

ORCID-Profile: Xiaosun Liu

Förderung

  • Key Research & Development Plan of Zhejiang Province
  • National Natural Science Foundation of China
  • Science and Technological Innovation Project for College Students in Zhejiang Province (Xinmiao Talent Plan)

Zitieren

APA

He, C., Zhu, K., Guo, Q., Chen, L., Wu, D., Lin, L., Zhang, X., Shen, Q., Liu, W., Zhang, Q., Wang, X., Hu, P., Zheng, Z., Wang, X., Yan, Z., Zhang, Q., Shou, C., Si, Y., Wu, X., …, & Liu, X. (2025). High Loss of Adipose Tissue During Neoadjuvant Chemotherapy Predicts Poor Prognosis in Patients With Gastric Cancer. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70107

Vancouver

He C, Zhu K, Guo Q, Chen L, Wu D, Lin L, et al. High Loss of Adipose Tissue During Neoadjuvant Chemotherapy Predicts Poor Prognosis in Patients With Gastric Cancer. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.70107

BibTeX
@article{He2025,
  author = {He, Chiyu and Zhu, Kankai and Guo, Qingqu and Chen, Li and Wu, Dan and Lin, Lele and Zhang, Xiaoyong and Shen, Qianyun and Liu, Weihuai and Zhang, Qi and Wang, Xinbao and Hu, Ping and Zheng, Zhiqiang and Wang, Xianfa and Yan, Zhilong and Zhang, Qing and Shou, Chunhui and Si, Yongqiang and Wu, Xingnan and Gao, Tianzhe and Gao, Yuan and Yu, Jiren and Liu, Xiaosun},
  title = {High Loss of Adipose Tissue During Neoadjuvant Chemotherapy Predicts Poor Prognosis in Patients With Gastric Cancer},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.70107}
}
Kostenlos starten →